Maastricht, the Netherlands – The Maastricht University Medical
Centre (UMC+), University Medical Center Aachen (UKA) and Royal
Philips Electronics N.V. have today announced that they are to set
up a strategic partnership, the aim of which is to pool their
knowledge, expertise and experience in the field of healthcare. The
planned cooperation will make it possible for new scientific
findings to be made available more quickly for routine application
in hospitals, thus benefiting patients. The universities of Aachen
and Maastricht are also supporting the initiative.
From left to right: Prof. Henning Saß, Dr. Henk van Houten
and
Guy Peeters MD
Among others, Prof. Henning Saß and Guy Peeters MD, chairmen of the
Boards of Management of the Aachen and Maastricht medical centers
respectively, Dr. Henk van Houten, head of the Healthcare Research
Program at Philips Research, and Jochen Franke, CEO Philips
Healthcare DACH (Germany, Austria and Switzerland), signed a letter
of intent at the ‘Biomedica 2008’ international Life Science Summit
in Maastricht, the Netherlands. The signing took place in the
presence of Mrs M. van der Hoeven and Mrs C. Thoben, Ministers of
Economic Affairs for the Netherlands and the German federal state of
North-Rhine Westphalia respectively, and Prof. Andreas Pinkwart,
Minister for Research and Innovation in North-Rhine Westphalia.
Philips and the two university medical centers intend to work
closely together and to combine their advanced clinical knowledge
and research specifically in the fields of cardiovascular disease
and cancer treatment. Their cooperation will cover the research,
development and application of new diagnostic and treatment methods.
Among other things, the partners’ aim is to set up a joint research
program in the field of medical imaging technology.
“Shortages in the labor market and increasing competition in the
healthcare sector are making it increasingly important to set up
international joint ventures to ensure that we can continue bringing
about the necessary innovation. National boundaries should not be a
barrier to this,” says Mr G. Peeters, chairman of the Board of
Management of the Maastricht UMC+.
Prof. Henning Saß, chairman of the Board of Management of the
University Clinic in Aachen comments, “This will benefit both the
patient and the participating partners, because it will enable us
all to strengthen our European and international competitive
position.”
Dr. Henk van Houten, Senior Vice President Philips Research, who is
in charge of the healthcare research program at Philips Research,
adds, “This alliance will give rise to advanced clinical care, as
well as ground-breaking clinical research to find an integrated
approach to diagnosis and therapy for cancer and cardiovascular
disease. The opportunity to work together with highly reputable
academic partners in order to link clinical research and healthcare
to the application of new medical technologies represents a very
exciting prospect for Philips.”
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a
global leader in healthcare, lighting and consumer lifestyle, delivering
people-centric, innovative products, services and solutions through the brand
promise of “sense and simplicity”. Headquartered in the Netherlands, Philips
employs approximately 134,200 employees in more than 60 countries worldwide.
With sales of EUR 27 billion in 2007, the company is a market leader in medical
diagnostic imaging and patient monitoring systems, energy efficient lighting
solutions, as well as lifestyle solutions for personal wellbeing. News from Philips is located at
www.philips.com/newscenter.